-
1.
公开(公告)号:US20100113788A1
公开(公告)日:2010-05-06
申请号:US12630171
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-keto morphinans.
摘要翻译: 本发明涉及6-酮吗啡喃的制备。
-
2.
公开(公告)号:US20100081818A1
公开(公告)日:2010-04-01
申请号:US12630192
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/00
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-hydroxy morphinans having formula (II) or N-alkylated 6-hydroxy morphinans having formula (III).
摘要翻译: 本发明涉及具有式(II)的6-羟基吗啡烷或具有式(III)的N-烷基化的6-羟基吗啡喃的制备。
-
3.
公开(公告)号:US08273888B2
公开(公告)日:2012-09-25
申请号:US12630171
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/02 , C07D489/08
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-keto morphinans.
摘要翻译: 本发明涉及6-酮吗啡喃的制备。
-
4.
公开(公告)号:US20100041888A1
公开(公告)日:2010-02-18
申请号:US12444421
申请日:2008-05-02
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the conversion of a 6-keto morphinan to a 6-alpha-hydroxy morphinan in the presence of a ruthenium, rhodium, or iridium asymmetric catalyst and a hydrogen source.
摘要翻译: 本发明涉及在钌,铑或铱不对称催化剂和氢源的存在下将6-酮基吗啡喃转化为6-α-羟基吗啡喃。
-
5.
公开(公告)号:US08524904B2
公开(公告)日:2013-09-03
申请号:US12630192
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/08 , C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-hydroxy morphinans having formula (II) or N-alkylated 6-hydroxy morphinans having formula (III).
摘要翻译: 本发明涉及具有式(II)的6-羟基吗啡烷或具有式(III)的N-烷基化的6-羟基吗啡喃的制备。
-
6.
公开(公告)号:US07985858B2
公开(公告)日:2011-07-26
申请号:US12444421
申请日:2008-05-02
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/08 , C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the conversion of a 6-keto morphinan to a 6-alpha-hydroxy morphinan in the presence of a ruthenium, rhodium, or iridium asymmetric catalyst and a hydrogen source.
摘要翻译: 本发明涉及在钌,铑或铱不对称催化剂和氢源的存在下将6-酮基吗啡喃转化为6-α-羟基吗啡喃。
-
公开(公告)号:US08148528B2
公开(公告)日:2012-04-03
申请号:US12469951
申请日:2009-05-21
申请人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
发明人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
IPC分类号: C07D489/08
CPC分类号: C07D489/02 , C07D221/28 , C07D489/08
摘要: The invention generally provides processes and intermediate compounds useful for the production of normorphinans and derivatives of normorphinans.
摘要翻译: 本发明通常提供可用于生产正丝菌素和正大脑啡肽衍生物的方法和中间体化合物。
-
公开(公告)号:US20090299069A1
公开(公告)日:2009-12-03
申请号:US12469951
申请日:2009-05-21
申请人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
发明人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
IPC分类号: C07D489/08
CPC分类号: C07D489/02 , C07D221/28 , C07D489/08
摘要: The invention generally provides processes and intermediate compounds useful for the production of normorphinans and derivatives of normorphinans.
摘要翻译: 本发明通常提供可用于生产正丝菌素和正大脑啡肽衍生物的方法和中间体化合物。
-
公开(公告)号:US08252808B2
公开(公告)日:2012-08-28
申请号:US12316862
申请日:2008-12-17
申请人: Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Bobby N. Trawick , Todd Osiek , Subo Liao , Frank W. Moser , Joseph P. McClurg
发明人: Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Bobby N. Trawick , Todd Osiek , Subo Liao , Frank W. Moser , Joseph P. McClurg
IPC分类号: C07D221/28 , A61K31/4748
CPC分类号: C07D221/22 , C07D489/04
摘要: The invention generally provides processes and intermediate compounds useful for the production of (+)-opiates. Non-limiting examples of (+) opiates that may be derived from one or more compounds of the invention include (+)-noroxymorphone, (+)-naltrexone, (+)-naloxone, (+)-N-cyclopropylmethylnorhydrocodone, (+)-N-cycloproylmethylnorhydromorphone, (+)-N-allylnorhydrocodone, (+)-N-allylnorhydromorphone, (+)-noroxycodone, (+)-naltrexol, (+)-naloxol, and (+)-3-O-methyl-naltrexone.
摘要翻译: 本发明通常提供用于生产(+) - 阿片剂的方法和中间体化合物。 可以衍生自本发明的一种或多种化合物的(+)阿片剂的非限制性实例包括(+) - 去甲吗啡酮,(+) - 纳曲酮,(+) - 纳洛酮,(+) - N-环丙基甲基氢可酮,(+ )-N-环丙基甲基氢去甲基酮,(+) - N-烯丙基去氢可酮,(+) - N-烯丙基去甲低聚酮,(+) - 诺酮可龙,(+) - 纳曲酮,(+) - 纳洛酮和(+) - - 纳曲酮
-
公开(公告)号:US07999105B2
公开(公告)日:2011-08-16
申请号:US12372788
申请日:2009-02-18
申请人: Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Frank W. Moser , Jian Bao
发明人: Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Frank W. Moser , Jian Bao
IPC分类号: C07D489/02 , C07D221/22 , C07F5/02
CPC分类号: C07D489/02 , C07F5/025
摘要: Processes are described for the synthesis of 3-hydroxymorphinan derivatives by hydrolysis of side products from the O-demethylation of 3-methoxymorphinan derivatives.
摘要翻译: 描述了通过从3-甲氧基吗啡喃衍生物的O-脱甲基化水解副产物来合成3-羟基吗啡喃衍生物的方法。
-
-
-
-
-
-
-
-
-